INFUSYSTEM HOLDINGS, INC (INFU) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 0.00 USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 20.42M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 97.70M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $0.00 | $20.42M | (m) | (m) | $97.70M | (m) |
| 2026-03-31 | (m) | (m) | $0.00 | $19.65M | (m) | (m) | $98.66M | (m) |
| 2025-12-31 | (m) | (m) | $0.00 | $19.63M | (m) | (m) | $100.56M | (m) |
| 2025-09-30 | (m) | (m) | $0.00 | $20.93M | (m) | (m) | $98.88M | (m) |
| 2025-06-30 | (m) | (m) | $0.00 | $26.35M | (m) | (m) | $100.85M | (m) |
| 2025-03-31 | (m) | (m) | $0.00 | $28.71M | (m) | (m) | $104.28M | (m) |
| 2024-12-31 | (m) | (m) | $0.00 | $23.86M | (m) | (m) | $103.61M | (m) |
| 2024-09-30 | (m) | (m) | $0.00 | $27.98M | (m) | (m) | $105.30M | (m) |
| 2024-06-30 | (m) | (m) | $0.00 | $34.16M | (m) | (m) | $108.53M | (m) |
| 2024-03-31 | (m) | (m) | $0.00 | $29.93M | (m) | (m) | $104.85M | (m) |
| 2023-12-31 | (m) | (m) | $0.00 | $29.10M | (m) | (m) | $102.92M | (m) |
| 2023-09-30 | (m) | (m) | $0.00 | $32.66M | (m) | (m) | $102.07M | (m) |
| 2023-06-30 | (m) | (m) | $0.00 | $36.14M | (m) | (m) | $102.75M | (m) |
| 2023-03-31 | (m) | (m) | $0.00 | $36.39M | (m) | (m) | $102.26M | (m) |
| 2022-12-31 | (m) | (m) | $0.00 | $33.16M | (m) | (m) | $99.39M | (m) |
| 2022-09-30 | (m) | (m) | $0.00 | $34.46M | (m) | (m) | $98.98M | (m) |
| 2022-06-30 | (m) | (m) | $0.00 | $33.69M | (m) | (m) | $98.82M | (m) |
| 2022-03-31 | (m) | (m) | $156.00K | $34.79M | (m) | (m) | $98.24M | (m) |
| 2021-12-31 | (m) | (m) | $349.00K | $32.75M | (m) | (m) | $97.59M | (m) |
| 2021-09-30 | (m) | (m) | $336.00K | $30.56M | (m) | (m) | $94.79M | (m) |
| 2021-06-30 | (m) | (m) | $520.00K | $31.94M | (m) | (m) | $96.00M | (m) |
| 2021-03-31 | (m) | (m) | $671.00K | $31.75M | (m) | (m) | $90.59M | (m) |
| 2020-12-31 | (m) | (m) | $9.42M | $29.38M | (m) | (m) | $96.99M | (m) |
| 2020-09-30 | (m) | (m) | $7.76M | $27.03M | (m) | (m) | $80.31M | (m) |
| 2020-06-30 | (m) | (m) | $7.53M | $33.34M | (m) | (m) | $83.97M | (m) |
| 2020-03-31 | (m) | (m) | $7.29M | $32.33M | (m) | (m) | $82.68M | (m) |
| 2019-12-31 | (m) | (m) | $8.08M | $30.30M | (m) | (m) | $79.22M | (m) |
| 2019-09-30 | (m) | (m) | $7.01M | $30.34M | (m) | (m) | $77.89M | (m) |
| 2019-06-30 | (m) | (m) | $6.08M | $27.48M | (m) | (m) | $72.36M | (m) |
| 2019-03-31 | (m) | (m) | $5.34M | $27.52M | (m) | (m) | $67.25M | (m) |
| 2018-12-31 | (m) | (m) | $4.90M | $28.84M | (m) | (m) | $64.07M | (m) |
| 2018-09-30 | (m) | (m) | $4.78M | $28.66M | (m) | (m) | $63.99M | (m) |
| 2018-06-30 | (m) | (m) | $3.04M | $21.96M | (m) | (m) | $63.52M | (m) |
| 2018-03-31 | (m) | (m) | $3.04M | $22.72M | (m) | (m) | $64.97M | (m) |
| 2017-12-31 | (m) | (m) | $3.04M | $25.35M | (m) | (m) | $68.88M | (m) |
| 2017-09-30 | (m) | (m) | $2.85M | $26.54M | (m) | (m) | $85.33M | (m) |
| 2017-06-30 | (m) | (m) | $2.66M | $28.72M | (m) | (m) | $88.71M | (m) |
| 2017-03-31 | (m) | (m) | $30.37M | (m) | (m) | (m) | $91.89M | (m) |
| 2016-12-31 | (m) | (m) | $5.31M | $26.58M | (m) | (m) | $96.34M | (m) |
| 2016-09-30 | (m) | (m) | $7.28M | $31.36M | (m) | (m) | $97.09M | (m) |
| 2016-06-30 | (m) | (m) | $5.94M | $33.48M | (m) | (m) | $100.27M | (m) |
| 2016-03-31 | (m) | (m) | $5.18M | $32.43M | (m) | (m) | $100.16M | (m) |
| 2015-12-31 | (m) | (m) | $5.06M | $29.88M | (m) | (m) | $96.45M | (m) |
| 2015-09-30 | (m) | (m) | $5.27M | $29.97M | (m) | (m) | $93.78M | (m) |
| 2015-06-30 | (m) | (m) | $6.74M | $28.03M | (m) | (m) | $91.78M | (m) |
| 2015-03-31 | (m) | (m) | $5.54M | $28.08M | (m) | (m) | $87.47M | (m) |
| 2014-12-31 | (m) | (m) | $6.45M | $19.03M | (m) | (m) | $80.21M | (m) |
| 2014-09-30 | (m) | (m) | $4.24M | $23.63M | (m) | (m) | $81.02M | (m) |
| 2014-06-30 | (m) | (m) | $3.87M | $22.83M | (m) | (m) | $77.73M | (m) |
| 2014-03-31 | (m) | (m) | $5.30M | $21.86M | (m) | (m) | $78.25M | (m) |
| 2013-12-31 | (m) | (m) | $5.12M | $21.61M | (m) | (m) | $77.37M | (m) |
| 2013-09-30 | (m) | (m) | $3.24M | $24.38M | (m) | (m) | $76.39M | (m) |
| 2013-06-30 | (m) | (m) | $3.12M | $25.20M | (m) | (m) | $75.75M | (m) |
| 2013-03-31 | (m) | (m) | $3.87M | $24.59M | (m) | (m) | $76.23M | (m) |
| 2012-12-31 | (m) | (m) | $3.95M | $27.32M | (m) | (m) | $77.52M | (m) |
| 2012-09-30 | (m) | (m) | $22.40M | $1.93M | (m) | (m) | $74.02M | (m) |
| 2012-06-30 | (m) | (m) | $6.26M | $19.57M | (m) | (m) | $74.72M | (m) |
| 2012-03-31 | (m) | (m) | $6.30M | $21.01M | (m) | (m) | $75.63M | (m) |
| 2011-12-31 | (m) | (m) | $6.58M | $22.55M | (m) | (m) | $76.26M | (m) |
| 2011-09-30 | (m) | (m) | $6.67M | $24.13M | (m) | (m) | $79.49M | (m) |
| 2011-06-30 | (m) | (m) | $6.42M | $25.10M | (m) | (m) | $93.56M | (m) |
| 2010-12-31 | (m) | (m) | $5.55M | $26.65M | (m) | (m) | $130.36M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |